Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10046056 Glycotargeting therapeutics

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 17, 2016
Date of Patent
August 14, 2018
Patent Application Number
15185564
Patent Citations Received
‌
US Patent 11801305 Glycotargeting therapeutics
‌
US Patent 11253579 Compositions and methods for inducing immune tolerance
‌
US Patent 11654188 Glycotargeting therapeutics
0
‌
US Patent 11666638 Glycotargeting therapeutics
0
‌
US Patent 10800838 Erythrocyte-binding therapeutics
‌
US Patent 10821157 Glycotargeting therapeutics
‌
US Patent 10919963 Erythrocyte-binding therapeutics
‌
US Patent 10940209 Glycotargeting therapeutics
‌
US Patent 10946079 Glycotargeting therapeutics
‌
US Patent 10953101 Glycotargeting therapeutics
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10046056
Patent Primary Examiner
‌
Hasan Ahmed

Find more entities like US Patent 10046056 Glycotargeting therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo